JS Capital Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

JS Capital Management’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,000,000	Closed	-$11.6M	–	37
2021 Q4	$11.6M	Hold	1,000,000	–	–	0.53%	28
2021 Q3	$12.4M	Buy	+1,000,000	New	+$11.3M	0.72%	25

Other funds holding SLGC

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

MAM

Madryn Asset Management New York $34.1M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JS Capital Management's SLGC Position: Q1 2022 in Review

JS Capital Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2022, closing a stake of 1,000,000 shares — an estimated $11.6M sold.

JS Capital Management first reported a position in SLGC in Q3 2021 and held it in 2 quarters. The position peaked at $12.4M in Q3 2021. 115 funds tracked by Wall St. Rank hold SLGC as of Q1 2022.

JS Capital Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
JS Capital Management sold 1,000,000 SomaLogic, Inc. Class A Common Stock shares in Q1 2022, an estimated $11.6M.
JS Capital Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 2 quarters.
JS Capital Management's SomaLogic, Inc. Class A Common Stock position peaked at $12.4M in Q3 2021.
115 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2022.

Based on JS Capital Management's 13F filing for Q1 2022, filed 16 May 2022.